Submission Details
| 510(k) Number | K230602 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 03, 2023 |
| Decision Date | October 31, 2023 |
| Days to Decision | 242 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K230602 is an FDA 510(k) clearance for the Hudson RCI? TurboMist? Nebulizer System, a Nebulizer (direct Patient Interface) (Class II — Special Controls, product code CAF), submitted by Medline Industries, LP (Nortfield, US). The FDA issued a Cleared decision on October 31, 2023, 242 days after receiving the submission on March 3, 2023. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5630.
| 510(k) Number | K230602 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 03, 2023 |
| Decision Date | October 31, 2023 |
| Days to Decision | 242 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CAF — Nebulizer (direct Patient Interface) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5630 |